Journal
OSTEOARTHRITIS AND CARTILAGE
Volume 14, Issue 11, Pages 1163-1173Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.joca.2006.04.015
Keywords
proteinase-activated receptor-2; articular chondrocyte; osteoarthritis; IL-1 beta; TNF-alpha; TGF-beta
Categories
Ask authors/readers for more resources
Objective: To investigate the modulation of expression of proteinase-activated receptor-2 (PAR-2) in articular chondrocytes by inflammatory cytokines. Design: Articular synovium and cartilage tissues were collected from eight patients with osteoarthritis (OA), and three patients without arthropathy (normal). Chondrocytes were stimulated with interleukin (IL)-1 beta, tumor necrosis factor (TNF)-alpha or transforming growth factor (TGF)-beta 1. The expression of PAR-2 was detected using reverse transcriptase-polymerase chain reaction (PCR), Western blotting and immunofluorescence. Quantitative PCR was performed to assess the expression levels of PAR-2 messenger RNA (mRNA). Results: The expression of PAR-2 mRNA was demonstrated in both OA and normal chondrocytes as well as in synovial fibroblasts. However, the level of PAR-2 in OA chondrocytes was much higher than in normal chondrocytes. Long-term culture revealed that PAR-2 mRNA expression was maintained up to three passages in OA but not in normal chondrocytes. IL-1 beta and TNF-alpha both upregulated PAR-2 expression in normal and OA chondrocytes. In contrast, TGF-beta 1 significantly decreased expression of PAR-2 in OA chondrocytes but increased PAR-2 in normal chondrocytes. Conclusions: Overexpression of PAR-2 in OA chondrocytes is upregulated by proinflammatory cytokines IL-1 beta and TNF-alpha, and down-regulated by regulatory cytokine TGF-beta 1. PAR-2 may be involved in the pathogenesis of OA. (C) 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available